Paired with a cheap dual PEG16X boards like the Asrock 939SLI32-eSATA2, dual graphics with Chrome S27s is doable for under ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has been ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without regular ...

Researchers in Japan have developed an effective encapsulation with a PET front cover for copper indium gallium diselenide mini-modules. The lab devices withstood damp heat tests, retaining ...

After following XYZ Laboratories recent expansion in the news, I was pleased to see your advertisement for an analytical chemist (position 35872), in the August 7 issue of Chemical and Engineering ...

As a former claims handler and fraud investigator, Jason Metz has worked on a multitude of complex and multifaceted claims. The insurance industry can be seemingly opaque, and Jason enjoys breaking ...

Forbes asked 34 billionaires in early 2025 how they thought the S&P 500 would fare. Turns out, not even billionaires can see the future.